MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Inflammatory microglial and astroglial phenotype associated with pathological alpha-synuclein inclusions in the substantia nigra

    A. Stoll, M. Bensky, J. Patterson, C. Kemp, K. Steece-Collier, M. Hore, K. Luk, C. Sortwell (Grand Rapids, USA)

    Objective: To characterize neuroinflammatory gene expression in microglia and astrocytes associated with early alpha-synuclein (a-syn) inclusion formation. Background: Parkinson’s disease (PD) is characterized by alpha-synuclein…
  • 2022 International Congress

    Protective mechanism of melatonin via heat shock protein in the MPP+-induced in vitro Parkinson’s disease model

    YJ. Jung, E. Oh, A. Kim, H. Choi (Daejeon, Republic of Korea)

    Objective: The objective of this study was to investigate the protective properties of melatonin in an in vitro Parkinson’s disease (PD) model, especially focusing on…
  • 2022 International Congress

    Month 24 results of a virtual longitudinal, observational study of Parkinson’s disease: The AT-HOME PD cohort

    M. Zafar, J. Soto, E. Baloga, L. Omberg, E. Macklin, P. Snyder, K. Amodeo, T. Meyers, S. Duquette, C. Stevens, K. Lizzaraga, E. Nnadika, A. Sarkar, C. Tarolli, J. Adams, C. Lungu, J. Gottesman, B. Valdovinos, E. Dorsey, L. Mangravite, T. Simuni, M. Schwarzchild, R. Schneider (Rochester, USA)

    Objective: To describe the change in characteristics of Parkinson’s disease (PD) clinical trial participants over 24 months following trial participation in a remote, longitudinal observational…
  • 2022 International Congress

    Examining the sex differences in the prevalence and incidence of Parkinson disease

    A. Zirra, S. Rao, J. Bestwick, R. Rajalingam, C. Marras, C. Blauwendraat, I. Mata, A. Noyce (London, United Kingdom)

    Objective: The objective of this meta-analysis was to examine the male-to-female (M/F) incidence and prevalence of Parkinson disease. Background: Parkinson disease (PD) is a major…
  • 2022 International Congress

    Novel bi-allelic variants in FBXO7 in a family with young-onset typical Parkinson’s disease

    I. Keller Sarmiento, M. Afshari, L. Kinsley, V. Silani, S. Lubbe, N. Mencacci, D. Krainc (Chicago, USA)

    Objective: To describe the case of two brothers affected by typical young-onset Parkinson’s disease (PD), carrying novel compound heterozygous variants in FBXO7. Background: Bi-allelic mutations…
  • 2022 International Congress

    Prevalence, clinical and neuropsychiatric aspects of Sleep Disorders in Parkinson’s disease: a meta-analysis

    G. Maggi, F. Cerciello, I. Obeso, G. Santangelo (Caserta, Italy)

    Objective: The present meta-analysis aims to provide a reliable estimate of the prevalence and associated clinical and neuropsychiatric aspects of the most frequent sleep disorders…
  • 2022 International Congress

    Closing the gap: Increasing access to genetic testing and counseling for Hispanics through PD research

    P. Delgado Hodges, R. Deleon, A. Naito, R. Cruz Vicioso, A. Viñuelas, F. Velez Lago, L. Forastieri, I. F Mata (Indianapolis, USA)

    Objective: To report preliminary genetic findings of Hispanic participants from the PD GENEration Registry and GEN-EP Latino study. Background: The incidence of Parkinson disease across…
  • 2022 International Congress

    Performance of Parkinson´s disease cognitive scale rating scale (PD-CRS) after 2 years Subthalamic nucleus deep brain stimulation. Comparison with Mattis Dementia Rating Scale (MDRS) and Mini-Mental State Examination (MMSE)

    C. García-Sánchez, C. Pons, N. Grunden, B. Pascual-Sedano, A. Gironell, R. Rodriguez, J. Kulisevsky (Barcelona, Spain)

    Objective: To study the performance of PD-CRS before and 2 years after STN-DBS and compare their results with other recognized cognitive scales. Background: Parkinson´s disease…
  • 2022 International Congress

    Diagnostic Utility of I123-FP-CIT Single Photon Emission Computed Tomography for Patients with Clinically Uncertain Parkinsonian Syndrome

    R. Falconer, T. Hunter, E. Szabo, C. Brand (Alexandria, USA)

    Objective: This study investigated the impact of I123-FP-CIT single photon emission computed tomography (SPECT) for the diagnosis of patients with clinically uncertain parkinsonian syndrome (CUPS)…
  • 2022 International Congress

    DNA methylation differs between idiopathic Parkinson Disease and Healthy Control subjects in the Parkinson’s Progression Marker Initiative (PPMI) cohort

    P. Gonzalez-Latapi, B. Bustos, T. Simuni, S. Lubbe, D. Krainc (Chicago, USA)

    Objective: Compare baseline whole blood DNA methylation in unmedicated idiopathic Parkinson's Disease (iPD) and healthy control (HC) participants from PPMI Background: Epigenetic mechanisms like DNA…
  • « Previous Page
  • 1
  • …
  • 291
  • 292
  • 293
  • 294
  • 295
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley